Leukotrap - CP2D
- Product NDC
- 53157-455
- 11-digit product format
- 531570455
- Labeler code
- 53157
- Product ID
- 53157-455_e154f8b7-89a1-dfbb-e053-2995a90a300a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ANTICOAGULANT CITRATE PHOSPHATE DOUBLE DEXTROSE
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Haemonetics Corporation
- Application
- BN820915
- Marketing category
- NDA
- Marketing start
- 2019-10-09
- Marketing end
- 0000-00-00
- Substance
- DEXTROSE, UNSPECIFIED FORM
- Active strength
- 5 g/100mL
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 53157-455 | D | Discontinued by firm | 2026-08-17 | ||
| excluded package | package | 53157-455 | 53157-455-02 | D | Discontinued by firm | 2026-08-17 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Code | Status | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | D | Discontinued by firm | d630ba8d3edf… | 732f749b63fb… | |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 53157-455-02 | D | Discontinued by firm | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | D | Discontinued by firm | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 53157-455-02 | D | Discontinued by firm | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | D | Discontinued by firm | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 53157-455-02 | D | Discontinued by firm | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | D | Discontinued by firm | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 53157-455-02 | D | Discontinued by firm | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | D | Discontinued by firm | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 53157-455-02 | D | Discontinued by firm | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | D | Discontinued by firm | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 53157-455-02 | D | Discontinued by firm | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | D | Discontinued by firm | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 53157-455-02 | D | Discontinued by firm | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | U | Excluded because listing certification expired | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 53157-455-02 | U | Excluded because listing certification expired | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | U | Excluded because listing certification expired | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 53157-455-02 | U | Excluded because listing certification expired | 0efc9e666f02… | f202fb6c5f17… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Leukotrap RC System | CP2D/AS-3 ANTICOAGULANT AND ADDITIVE SYSTEM | GVS TM INC | 4c0dec79-1648-1cfd-e063-6394a90a88cc | 2026-07-03 | BN820915 | |
| Leukotrap WB System - CP2D | CP2D/AS-3 - ANTICOAGULANT AND ADDITIVE SYSTEM | GVS TM INC | 44a82ea8-69bf-f061-e063-6394a90af3da | 2026-07-03 | BN820915 | |
| Leukotrap WB system - CP2D | CP2D/AS-3 ANTICOAGULANT AND ADDITIVE SYSTEM | GVS TM INC | 42ece7e1-1da1-7e5a-e063-6294a90ac803 | 2026-07-03 | BN820915 | |
| Leukotrap WB System - CP2D | CP2D/AS-3 - ANTICOAGULANT AND ADDITIVE SYSTEM | GVS TM INC | 44a7d200-13cb-c0b0-e063-6294a90aafad | 2026-07-03 | BN820915 | |
| Leukotrap RC PL System | CP2D/AS-3 ANTICOAGULANT AND ADDITIVE SYSTEM | GVS TM INC | 54eab581-bc48-f9f0-e063-6394a90a4b93 | 2026-06-25 | BN820915 | |
| Leukotrap WB system - CP2D | CP2D/AS-3 ANTICOAGULANT AND ADDITIVE SYSTEM | GVS TM INC | 54fdf3cf-41df-af7d-e063-6294a90ab1e6 | 2026-06-24 | BN820915 | |
| Blood Collection System | CP2D/AS-3 TRIPLE WITH SAMPLING SYSTEM | GVS TM INC | 54e8cfd2-f91b-8381-e063-6394a90a3f77 | 2026-06-23 | BN820915 | |
| Leukotrap RC PL System | CP2D/AS-3 ANTICOAGULANT AND ADDITIVE SYSTEM | GVS TM INC | 54e9a497-7a94-44c9-e063-6294a90a84da | 2026-06-23 | BN820915 | |
| Leukotrap RC PL System | CP2D/AS-3 ANTICOAGULANT AND ADDITIVE SYSTEM | GVS TM INC | 54eb0462-cd00-4467-e063-6394a90aa371 | 2026-06-23 | BN820915 | |
| Leukotrap RC System | CP2D/AS-3 ANTICOAGULANT AND ADDITIVE SYSTEM | GVS TM INC | 54eb3c81-5cc8-03c4-e063-6294a90a2065 | 2026-06-23 | BN820915 | |
| Leukotrap RC System | CP2D/AS-3 ANTICOAGULANT AND ADDITIVE SYSTEM | GVS TM INC | 54ebb700-3bcf-d0e3-e063-6394a90a57c8 | 2026-06-23 | BN820915 | |
| AS-3 | AS-3 | GVS TM INC | 3dfa3397-fc13-4659-e063-6394a90a5abc | 2025-11-06 | Warnings | BN820915 |
| CP2D | CP2D | GVS TM INC | 3fa2e438-2ff0-a2df-e063-6394a90ac7b5 | 2025-11-06 | Warnings | BN820915 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 53157-455-02 | 53157045502 | 250 mL in 1 BAG (53157-455-02) | 250 ml | 2019-10-09 | 0000-00-00 | No | No | Current |